Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clopidogrel/omeprazole - Cogentus Pharmaceuticals

Next Previous
Search
Drug Profile

Clopidogrel/omeprazole - Cogentus Pharmaceuticals

Alternative Names: CGT-2168

Latest Information Update: 23 Mar 2010

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Cogentus Pharmaceuticals
  • Class 2 pyridinylmethylsulfinylbenzimidazoles; Antiplatelets; Antiulcers; Gastric antisecretories; Thiophenes
  • Mechanism of Action Platelet activating factor inhibitors; Platelet ADP receptor antagonists; Platelet aggregation inhibitors; Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Suspended Ischaemic heart disorders; Peptic ulcer

Most Recent Events

  • 17 Mar 2010 Drug interactions data from two clinical trials released by the European Medicines Agency
  • 03 Sep 2008 Pharmacokinetics data from a phase I trial in healthy volunteers presented at the Congress of the European Society of Cardiology (ESC-2008)
  • 16 Jun 2008 Phase-III clinical trials in Ischaemic heart disorders in Europe (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top